ATE146597T1 - Verfahren zur diagnose von hiv-infektionen - Google Patents

Verfahren zur diagnose von hiv-infektionen

Info

Publication number
ATE146597T1
ATE146597T1 AT91918279T AT91918279T ATE146597T1 AT E146597 T1 ATE146597 T1 AT E146597T1 AT 91918279 T AT91918279 T AT 91918279T AT 91918279 T AT91918279 T AT 91918279T AT E146597 T1 ATE146597 T1 AT E146597T1
Authority
AT
Austria
Prior art keywords
prosomes
extracellular
blood
suffering
diseases
Prior art date
Application number
AT91918279T
Other languages
English (en)
Inventor
Klaus Scherrer
Jean-Paul Bureau
Faycal Bey
Original Assignee
Pro Soma Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Soma Sarl filed Critical Pro Soma Sarl
Application granted granted Critical
Publication of ATE146597T1 publication Critical patent/ATE146597T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/20—Coumarin derivatives
    • C12Q2337/22—7-Amino-4-methylcoumarin, i.e. AMC, MCA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91918279T 1990-10-12 1991-10-11 Verfahren zur diagnose von hiv-infektionen ATE146597T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90402863 1990-10-12

Publications (1)

Publication Number Publication Date
ATE146597T1 true ATE146597T1 (de) 1997-01-15

Family

ID=8205762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918279T ATE146597T1 (de) 1990-10-12 1991-10-11 Verfahren zur diagnose von hiv-infektionen

Country Status (8)

Country Link
EP (1) EP0506914B1 (de)
JP (1) JPH05502799A (de)
AT (1) ATE146597T1 (de)
AU (1) AU652192B2 (de)
CA (1) CA2069417A1 (de)
DE (1) DE69123724T2 (de)
FI (1) FI922667A7 (de)
WO (1) WO1992007270A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL440782A1 (pl) * 2022-03-29 2023-10-02 Urteste Spółka Akcyjna Związek - marker diagnostyczny raka jelita, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka jelita, zestaw zawierający taki związek oraz zastosowania takiego związku i sposób leczenia raka jelita

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586814A1 (fr) * 1985-08-30 1987-03-06 Centre Nat Rech Scient Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules
JPH01309686A (ja) * 1988-06-08 1989-12-14 Otsuka Pharmaceut Co Ltd 多機能プロテアーゼ

Also Published As

Publication number Publication date
JPH05502799A (ja) 1993-05-20
DE69123724D1 (de) 1997-01-30
AU652192B2 (en) 1994-08-18
EP0506914A1 (de) 1992-10-07
AU8740691A (en) 1992-05-20
FI922667A0 (fi) 1992-06-09
EP0506914B1 (de) 1996-12-18
FI922667A7 (fi) 1992-06-09
CA2069417A1 (en) 1992-04-13
DE69123724T2 (de) 1997-04-10
WO1992007270A1 (en) 1992-04-30

Similar Documents

Publication Publication Date Title
DE69228436D1 (de) Monoklonaler Antikörper, der den C-Terminus von hBNP erkennt
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
Norden et al. Schistosoma mansoni, S. haematobium, and S. japonicum: identification of genus-, species-, and gender-specific antigenic worm glycoproteins
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
UA24003A (uk) Спосіб визhачеhhя специфічhої сеhсибілізації лімфоцитів
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
EP0232179A3 (en) Assay for human breast cancer
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
SE8004542L (sv) Diagnostiskt test
FI922666A0 (fi) Diagnostiskt foerfarande.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
DE69123724D1 (de) Verfahren zur diagnose von hiv-infektionen
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
DE3685700D1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
Murray et al. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
DE3688638D1 (de) Monoklonale antikoerper fuer humane lungenkarzinome des "nicht-kleine-zellen"-typs.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
Hearn et al. Aspergillus fumigatus antigens used in the serodiagnosis of aspergillosis
Tsianos et al. Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis.
Walker‐Deemin et al. Detection of circulating antigens in Gabonese patients with Loa loa filariasis
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
Goldwasser et al. Detection of C-reactive protein by fluorescent antibody techniques
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정